Skip to content
DataLookout
Menu

China National Center for Cardiovascular Diseases clinical trial pipeline

Get alerts when China National Center for Cardiovascular Diseases's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

12 trials changed in the last 30 days: 0 stopped, 6 with notable changes, 6 with minor changes only.

  1. Minor: 3 trials marked Unknown by the registry's verification sweep Changed Registry verification sweep3 trials
    1. Minor: Calcium-Phosphorus Regulation Therapy on Heart Valve Disease Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting China National Center for Cardiovascular DiseasesPhase 4 NCT06660524
    2. Minor: Goal Setting and Mobile-based Self-management Tool to Improve Diet Quality · High Blood Pressure Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting China National Center for Cardiovascular DiseasesNot applicable NCT06988501
    3. Minor: Risk Factors for Stroke or Systemic Embolism · Non-Valvular Atrial Fibrillation Registry Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting China National Center for Cardiovascular DiseasesNot specified NCT05598632
  2. Minor: SCOUT · Scalable Clinical Oversight of Large Language Models Via Uncertainty Triangulation Completed without a posted recruiting period China National Center for Cardiovascular DiseasesNot applicable NCT07414966
  3. Minor: Implementation of Machine Learning and Hemodynamic Profiles Based Clinical Decision Support Systems for Personalized Guideline Accordant Antihypertensive Regimens in Primary Care: a Pragmatic Cluster Randomized Controlled Trial Trial completed China National Center for Cardiovascular DiseasesNot applicable NCT06828692
  4. Notable: Vasopressor Agents in Pulmonary Hypertension Crisis Recruitment opened China National Center for Cardiovascular DiseasesNot applicable NCT07667829
  5. Notable: Ultrasound Guided Leadless Pacemaker Implantation Primary endpoint(s) modified China National Center for Cardiovascular DiseasesNot applicable NCT07857330
  6. Notable: Initiation of Tafolecimab · Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population Primary completion pushed from Nov 1, 2025 to Mar 1, 2028 China National Center for Cardiovascular DiseasesPhase 4 NCT06096909
  7. Notable: LoDoCo-TAVR · Low-dose Colchicine for Thromboprophylaxis After Transcatheter Aortic Valve Replacement Recruitment opened China National Center for Cardiovascular DiseasesNot applicable NCT07411768
  8. Minor: OCR-LLM-CHD · AI-Assisted Coronary Syndrome Subtyping From Admission History of Present Illness: A Clinician Reader Study Completed without a posted recruiting period China National Center for Cardiovascular DiseasesNot specified NCT07449429
  9. Notable: PRECISE-AFMR I · Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk Recruitment opened China National Center for Cardiovascular DiseasesNot applicable NCT07741253
  10. Notable: SMCs With LVH Compared to HCM Primary completion date changed from estimate of Dec 31, 2025 to Jul 20, 2026 China National Center for Cardiovascular DiseasesNot specified NCT07006974
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-16 NCT07938528 Strategy of Intracoronary Imaging Guided Drug-Coated Balloon Therapy for De Novo Lesions… Not Yet Recruiting
2026-11-12 NCT07932145 Early Mineralocorticoid Receptor Antagonist Therapy for Low-Renin Essential Hypertension Phase 4 Not Yet Recruiting
2026-11-10 NCT07927582 Pulsed Field Ablation for Atrial Fibrillation Under General Anesthesia Versus… Not Yet Recruiting
2026-11-09 NCT07926854 Unipolar Voltage-Guided Substrate Modification Plus Pulsed Field Ablation Pulmonary Vein… Not Yet Recruiting
2026-11-05 NCT07918781 Partial Cardiac Denervation for Preventing Atrial Fibrillation After CABG Not Yet Recruiting
2026-11-04 NCT07917078 Reduced-Dose Thrombolysis in Intermediate-Risk Pulmonary Embolism With High-Risk Features Phase 3 Not Yet Recruiting
2026-11-04 NCT07917676 Multimodal AI-Driven Out-of-Hospital Management for Hypertension and Cardiometabolic Risk Not Yet Recruiting
2026-11-03 NCT07912671 Out-Patient Proactive Observation With Wearable-Assisted Tracking for Cardiovascular… Not Yet Recruiting
2026-10-27 NCT07896980 MRI-guided Ventricular Tachycardia Ablation in Patients With Structural Heart Disease Not Yet Recruiting
2026-10-23 NCT07891052 Wearable Ultrasound for Cardiac Monitoring During Surgery and in Intensive Care Not Yet Recruiting

Active trials by phase

Early Phase 1
1
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
19
Not charted: 96 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Get alerts when China National Center for Cardiovascular Diseases's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free